ID ATF6B_HUMAN Reviewed; 703 AA. AC Q99941; B0UYX6; Q13269; Q14343; Q14345; Q5SSW7; Q99635; Q99637; Q9H3V9; AC Q9H3W1; Q9NPL0; DT 23-JAN-2002, integrated into UniProtKB/Swiss-Prot. DT 23-JAN-2002, sequence version 2. DT 27-MAR-2024, entry version 214. DE RecName: Full=Cyclic AMP-dependent transcription factor ATF-6 beta; DE Short=cAMP-dependent transcription factor ATF-6 beta; DE AltName: Full=Activating transcription factor 6 beta; DE Short=ATF6-beta; DE AltName: Full=Protein G13; DE AltName: Full=cAMP response element-binding protein-related protein; DE Short=Creb-rp; DE AltName: Full=cAMP-responsive element-binding protein-like 1; DE Contains: DE RecName: Full=Processed cyclic AMP-dependent transcription factor ATF-6 beta; GN Name=ATF6B; Synonyms=CREBL1, G13; OS Homo sapiens (Human). OC Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia; OC Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae; OC Homo. OX NCBI_TaxID=9606; RN [1] RP NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1). RC TISSUE=Tonsil; RX PubMed=8586413; DOI=10.1006/geno.1995.9891; RA Min J., Shukla H., Kozono H., Bronson S.K., Weissman S.M., Chaplin D.D.; RT "A novel Creb family gene telomeric of HLA-DRA in the HLA complex."; RL Genomics 30:149-156(1995). RN [2] RP NUCLEOTIDE SEQUENCE [GENOMIC DNA / MRNA] (ISOFORM 2). RX PubMed=8870652; DOI=10.1042/bj3190081; RA Khanna A., Campbell R.D.; RT "The gene G13 in the class III region of the human MHC encodes a potential RT DNA-binding protein."; RL Biochem. J. 319:81-89(1996). RN [3] RP NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA]. RX PubMed=14656967; DOI=10.1101/gr.1736803; RA Xie T., Rowen L., Aguado B., Ahearn M.E., Madan A., Qin S., Campbell R.D., RA Hood L.; RT "Analysis of the gene-dense major histocompatibility complex class III RT region and its comparison to mouse."; RL Genome Res. 13:2621-2636(2003). RN [4] RP NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA]. RX PubMed=14574404; DOI=10.1038/nature02055; RA Mungall A.J., Palmer S.A., Sims S.K., Edwards C.A., Ashurst J.L., RA Wilming L., Jones M.C., Horton R., Hunt S.E., Scott C.E., Gilbert J.G.R., RA Clamp M.E., Bethel G., Milne S., Ainscough R., Almeida J.P., Ambrose K.D., RA Andrews T.D., Ashwell R.I.S., Babbage A.K., Bagguley C.L., Bailey J., RA Banerjee R., Barker D.J., Barlow K.F., Bates K., Beare D.M., Beasley H., RA Beasley O., Bird C.P., Blakey S.E., Bray-Allen S., Brook J., Brown A.J., RA Brown J.Y., Burford D.C., Burrill W., Burton J., Carder C., Carter N.P., RA Chapman J.C., Clark S.Y., Clark G., Clee C.M., Clegg S., Cobley V., RA Collier R.E., Collins J.E., Colman L.K., Corby N.R., Coville G.J., RA Culley K.M., Dhami P., Davies J., Dunn M., Earthrowl M.E., Ellington A.E., RA Evans K.A., Faulkner L., Francis M.D., Frankish A., Frankland J., RA French L., Garner P., Garnett J., Ghori M.J., Gilby L.M., Gillson C.J., RA Glithero R.J., Grafham D.V., Grant M., Gribble S., Griffiths C., RA Griffiths M.N.D., Hall R., Halls K.S., Hammond S., Harley J.L., Hart E.A., RA Heath P.D., Heathcott R., Holmes S.J., Howden P.J., Howe K.L., Howell G.R., RA Huckle E., Humphray S.J., Humphries M.D., Hunt A.R., Johnson C.M., RA Joy A.A., Kay M., Keenan S.J., Kimberley A.M., King A., Laird G.K., RA Langford C., Lawlor S., Leongamornlert D.A., Leversha M., Lloyd C.R., RA Lloyd D.M., Loveland J.E., Lovell J., Martin S., Mashreghi-Mohammadi M., RA Maslen G.L., Matthews L., McCann O.T., McLaren S.J., McLay K., McMurray A., RA Moore M.J.F., Mullikin J.C., Niblett D., Nickerson T., Novik K.L., RA Oliver K., Overton-Larty E.K., Parker A., Patel R., Pearce A.V., Peck A.I., RA Phillimore B.J.C.T., Phillips S., Plumb R.W., Porter K.M., Ramsey Y., RA Ranby S.A., Rice C.M., Ross M.T., Searle S.M., Sehra H.K., Sheridan E., RA Skuce C.D., Smith S., Smith M., Spraggon L., Squares S.L., Steward C.A., RA Sycamore N., Tamlyn-Hall G., Tester J., Theaker A.J., Thomas D.W., RA Thorpe A., Tracey A., Tromans A., Tubby B., Wall M., Wallis J.M., RA West A.P., White S.S., Whitehead S.L., Whittaker H., Wild A., Willey D.J., RA Wilmer T.E., Wood J.M., Wray P.W., Wyatt J.C., Young L., Younger R.M., RA Bentley D.R., Coulson A., Durbin R.M., Hubbard T., Sulston J.E., Dunham I., RA Rogers J., Beck S.; RT "The DNA sequence and analysis of human chromosome 6."; RL Nature 425:805-811(2003). RN [5] RP NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA]. RA Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L., Mobarry C.M., RA Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R., Flanigan M.J., RA Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V., Hannenhalli S., RA Turner R., Yooseph S., Lu F., Nusskern D.R., Shue B.C., Zheng X.H., RA Zhong F., Delcher A.L., Huson D.H., Kravitz S.A., Mouchard L., Reinert K., RA Remington K.A., Clark A.G., Waterman M.S., Eichler E.E., Adams M.D., RA Hunkapiller M.W., Myers E.W., Venter J.C.; RL Submitted (JUL-2005) to the EMBL/GenBank/DDBJ databases. RN [6] RP PARTIAL NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 2). RX PubMed=8923003; DOI=10.1093/hmg/5.11.1749; RA Speek M., Barry F., Miller W.L.; RT "Alternate promoters and alternate splicing of human tenascin-X, a gene RT with 5' and 3' ends buried in other genes."; RL Hum. Mol. Genet. 5:1749-1758(1996). RN [7] RP FUNCTION, SUBCELLULAR LOCATION, AND PROTEOLYTIC CLEAVAGE. RX PubMed=11256944; DOI=10.1042/0264-6021:3550019; RA Haze K., Okada T., Yoshida H., Yanagi H., Yura T., Negishi M., Mori K.; RT "Identification of the G13 (cAMP-response-element-binding protein-related RT protein) gene product related to activating transcription factor 6 as a RT transcriptional activator of the mammalian unfolded protein response."; RL Biochem. J. 355:19-28(2001). RN [8] RP ACETYLATION [LARGE SCALE ANALYSIS] AT ALA-2, CLEAVAGE OF INITIATOR RP METHIONINE [LARGE SCALE ANALYSIS], AND IDENTIFICATION BY MASS SPECTROMETRY RP [LARGE SCALE ANALYSIS]. RX PubMed=22223895; DOI=10.1074/mcp.m111.015131; RA Bienvenut W.V., Sumpton D., Martinez A., Lilla S., Espagne C., Meinnel T., RA Giglione C.; RT "Comparative large-scale characterisation of plant vs. mammal proteins RT reveals similar and idiosyncratic N-alpha acetylation features."; RL Mol. Cell. Proteomics 11:M111.015131-M111.015131(2012). RN [9] RP ACETYLATION [LARGE SCALE ANALYSIS] AT ALA-2, CLEAVAGE OF INITIATOR RP METHIONINE [LARGE SCALE ANALYSIS], AND IDENTIFICATION BY MASS SPECTROMETRY RP [LARGE SCALE ANALYSIS]. RX PubMed=22814378; DOI=10.1073/pnas.1210303109; RA Van Damme P., Lasa M., Polevoda B., Gazquez C., Elosegui-Artola A., RA Kim D.S., De Juan-Pardo E., Demeyer K., Hole K., Larrea E., Timmerman E., RA Prieto J., Arnesen T., Sherman F., Gevaert K., Aldabe R.; RT "N-terminal acetylome analyses and functional insights of the N-terminal RT acetyltransferase NatB."; RL Proc. Natl. Acad. Sci. U.S.A. 109:12449-12454(2012). CC -!- FUNCTION: [Cyclic AMP-dependent transcription factor ATF-6 beta]: CC Precursor of the transcription factor form (Processed cyclic AMP- CC dependent transcription factor ATF-6 beta), which is embedded in the CC endoplasmic reticulum membrane (PubMed:11256944). Endoplasmic reticulum CC stress promotes processing of this form, releasing the transcription CC factor form that translocates into the nucleus, where it activates CC transcription of genes involved in the unfolded protein response (UPR) CC (PubMed:11256944). {ECO:0000269|PubMed:11256944}. CC -!- FUNCTION: [Processed cyclic AMP-dependent transcription factor ATF-6 CC beta]: Transcription factor that acts in the unfolded protein response CC (UPR) pathway by activating UPR target genes induced during ER stress CC (PubMed:11256944). Binds DNA on the 5'-CCAC[GA]-3' half of the ER CC stress response element (ERSE) (5'-CCAATN(9)CCAC[GA]-3') when NF-Y is CC bound to ERSE (PubMed:11256944). {ECO:0000269|PubMed:11256944}. CC -!- SUBUNIT: [Processed cyclic AMP-dependent transcription factor ATF-6 CC beta]: Homodimer and heterodimer with ATF6-alpha. The dimer interacts CC with the nuclear transcription factor Y (NF-Y) trimer through direct CC binding to NF-Y subunit C (NF-YC). {ECO:0000269|PubMed:11256944}. CC -!- INTERACTION: CC Q99941; P18850: ATF6; NbExp=2; IntAct=EBI-2841031, EBI-852157; CC Q99941; P17861: XBP1; NbExp=2; IntAct=EBI-2841031, EBI-6942961; CC Q99941; PRO_0000037575 [P27958]; Xeno; NbExp=5; IntAct=EBI-2841031, EBI-8763498; CC -!- SUBCELLULAR LOCATION: Endoplasmic reticulum membrane CC {ECO:0000269|PubMed:11256944}; Single-pass type II membrane protein CC {ECO:0000255}. CC -!- SUBCELLULAR LOCATION: [Processed cyclic AMP-dependent transcription CC factor ATF-6 beta]: Nucleus {ECO:0000269|PubMed:11256944}. Note=Under CC ER stress the cleaved N-terminal cytoplasmic domain translocates into CC the nucleus. {ECO:0000269|PubMed:11256944}. CC -!- ALTERNATIVE PRODUCTS: CC Event=Alternative splicing; Named isoforms=2; CC Name=2; CC IsoId=Q99941-1; Sequence=Displayed; CC Name=1; CC IsoId=Q99941-2; Sequence=VSP_000593; CC -!- TISSUE SPECIFICITY: Ubiquitous. {ECO:0000269|PubMed:11256944}. CC -!- DOMAIN: The basic domain functions as a nuclear localization signal. CC {ECO:0000269|PubMed:11256944}. CC -!- DOMAIN: The basic leucine-zipper domain is sufficient for association CC with the NF-Y trimer and binding to ERSE. CC {ECO:0000269|PubMed:11256944}. CC -!- PTM: N-glycosylated. {ECO:0000269|PubMed:11256944}. CC -!- PTM: During unfolded protein response, a fragment of approximately 60 CC kDa containing the cytoplasmic transcription factor domain is released CC by proteolysis. The cleavage is probably performed sequentially by CC site-1 (MBTPS1, S1P) and site-2 (MBTPS2, S2P) proteases. CC {ECO:0000305|PubMed:11256944}. CC -!- SIMILARITY: Belongs to the bZIP family. ATF subfamily. {ECO:0000305}. CC -!- SEQUENCE CAUTION: CC Sequence=AAC50888.1; Type=Frameshift; Evidence={ECO:0000305}; CC Sequence=AAG14898.1; Type=Frameshift; Evidence={ECO:0000305}; CC --------------------------------------------------------------------------- CC Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms CC Distributed under the Creative Commons Attribution (CC BY 4.0) License CC --------------------------------------------------------------------------- DR EMBL; U31903; AAA97438.1; -; mRNA. DR EMBL; X98053; CAA66663.1; -; Genomic_DNA. DR EMBL; X98054; CAA66664.1; -; mRNA. DR EMBL; U89337; AAB47487.1; -; Genomic_DNA. DR EMBL; AL049547; CAB89295.1; -; Genomic_DNA. DR EMBL; AL662828; -; NOT_ANNOTATED_CDS; Genomic_DNA. DR EMBL; AL662884; -; NOT_ANNOTATED_CDS; Genomic_DNA. DR EMBL; CR753803; -; NOT_ANNOTATED_CDS; Genomic_DNA. DR EMBL; CR925796; -; NOT_ANNOTATED_CDS; Genomic_DNA. DR EMBL; CH471081; EAX03581.1; -; Genomic_DNA. DR EMBL; CH471081; EAX03583.1; -; Genomic_DNA. DR EMBL; U52694; AAG14900.1; -; Genomic_DNA. DR EMBL; U52696; AAC50888.1; ALT_FRAME; mRNA. DR EMBL; U52693; AAG14898.1; ALT_FRAME; Genomic_DNA. DR EMBL; U52701; AAC50883.1; ALT_SEQ; mRNA. DR CCDS; CCDS4737.1; -. [Q99941-1] DR CCDS; CCDS47408.1; -. [Q99941-2] DR RefSeq; NP_001129625.1; NM_001136153.1. [Q99941-2] DR RefSeq; NP_004372.3; NM_004381.4. [Q99941-1] DR AlphaFoldDB; Q99941; -. DR SMR; Q99941; -. DR BioGRID; 107778; 75. DR ComplexPortal; CPX-6595; bZIP transcription factor complex, ATF6-ATF6B. DR ComplexPortal; CPX-6596; bZIP transcription factor complex, ATF6B-ATF6B. DR ComplexPortal; CPX-6600; bZIP transcription factor complex, ATF6B-XBP1. DR ComplexPortal; CPX-6601; bZIP transcription factor complex, ATF6B-CREBZF. DR IntAct; Q99941; 24. DR STRING; 9606.ENSP00000364349; -. DR GlyCosmos; Q99941; 6 sites, 1 glycan. DR GlyGen; Q99941; 7 sites, 2 O-linked glycans (2 sites). DR iPTMnet; Q99941; -. DR PhosphoSitePlus; Q99941; -. DR BioMuta; ATF6B; -. DR DMDM; 20137431; -. DR EPD; Q99941; -. DR jPOST; Q99941; -. DR MassIVE; Q99941; -. DR MaxQB; Q99941; -. DR PaxDb; 9606-ENSP00000364349; -. DR PeptideAtlas; Q99941; -. DR ProteomicsDB; 78531; -. [Q99941-1] DR ProteomicsDB; 78532; -. [Q99941-2] DR Pumba; Q99941; -. DR Antibodypedia; 49313; 220 antibodies from 32 providers. DR Antibodypedia; 7841; 34 antibodies from 3 providers. DR DNASU; 1388; -. DR Ensembl; ENST00000293709.10; ENSP00000293709.6; ENSG00000168468.12. [Q99941-1] DR Ensembl; ENST00000375201.8; ENSP00000364347.4; ENSG00000213676.13. [Q99941-2] DR Ensembl; ENST00000375203.8; ENSP00000364349.3; ENSG00000213676.13. [Q99941-1] DR Ensembl; ENST00000383156.8; ENSP00000372642.4; ENSG00000168468.12. [Q99941-2] DR Ensembl; ENST00000425571.6; ENSP00000404814.2; ENSG00000228628.8. [Q99941-1] DR Ensembl; ENST00000427136.6; ENSP00000404725.2; ENSG00000234539.9. [Q99941-1] DR Ensembl; ENST00000435768.6; ENSP00000399764.2; ENSG00000228628.8. [Q99941-2] DR Ensembl; ENST00000439240.6; ENSP00000391131.2; ENSG00000234539.9. [Q99941-2] DR GeneID; 1388; -. DR KEGG; hsa:1388; -. DR MANE-Select; ENST00000375203.8; ENSP00000364349.3; NM_004381.5; NP_004372.3. DR UCSC; uc003nzn.4; human. [Q99941-1] DR AGR; HGNC:2349; -. DR CTD; 1388; -. DR DisGeNET; 1388; -. DR GeneCards; ATF6B; -. DR HGNC; HGNC:2349; ATF6B. DR HPA; ENSG00000213676; Low tissue specificity. DR MIM; 600984; gene. DR neXtProt; NX_Q99941; -. DR OpenTargets; ENSG00000213676; -. DR PharmGKB; PA164716250; -. DR VEuPathDB; HostDB:ENSG00000213676; -. DR eggNOG; KOG4343; Eukaryota. DR GeneTree; ENSGT00940000160798; -. DR HOGENOM; CLU_026136_0_0_1; -. DR InParanoid; Q99941; -. DR OMA; FKCESME; -. DR OrthoDB; 5396881at2759; -. DR PhylomeDB; Q99941; -. DR TreeFam; TF316079; -. DR PathwayCommons; Q99941; -. DR Reactome; R-HSA-8874177; ATF6B (ATF6-beta) activates chaperones. DR SignaLink; Q99941; -. DR SIGNOR; Q99941; -. DR BioGRID-ORCS; 1388; 22 hits in 1184 CRISPR screens. DR ChiTaRS; ATF6B; human. DR GeneWiki; CREBL1; -. DR GenomeRNAi; 1388; -. DR Pharos; Q99941; Tbio. DR PRO; PR:Q99941; -. DR Proteomes; UP000005640; Chromosome 6. DR RNAct; Q99941; Protein. DR Bgee; ENSG00000168468; Expressed in thyroid gland. DR ExpressionAtlas; Q99941; baseline and differential. DR GO; GO:0000785; C:chromatin; ISA:NTNU_SB. DR GO; GO:0005829; C:cytosol; TAS:Reactome. DR GO; GO:0005789; C:endoplasmic reticulum membrane; IDA:ParkinsonsUK-UCL. DR GO; GO:0005794; C:Golgi apparatus; TAS:ParkinsonsUK-UCL. DR GO; GO:0000139; C:Golgi membrane; TAS:Reactome. DR GO; GO:0005654; C:nucleoplasm; TAS:Reactome. DR GO; GO:0005634; C:nucleus; IDA:ParkinsonsUK-UCL. DR GO; GO:0032993; C:protein-DNA complex; IDA:ParkinsonsUK-UCL. DR GO; GO:0090575; C:RNA polymerase II transcription regulator complex; IDA:NTNU_SB. DR GO; GO:0003700; F:DNA-binding transcription factor activity; IDA:ParkinsonsUK-UCL. DR GO; GO:0000981; F:DNA-binding transcription factor activity, RNA polymerase II-specific; ISA:NTNU_SB. DR GO; GO:1990837; F:sequence-specific double-stranded DNA binding; IDA:ARUK-UCL. DR GO; GO:0000976; F:transcription cis-regulatory region binding; IDA:ParkinsonsUK-UCL. DR GO; GO:0036500; P:ATF6-mediated unfolded protein response; TAS:ParkinsonsUK-UCL. DR GO; GO:0030968; P:endoplasmic reticulum unfolded protein response; IBA:GO_Central. DR GO; GO:1903892; P:negative regulation of ATF6-mediated unfolded protein response; IDA:UniProtKB. DR GO; GO:0045944; P:positive regulation of transcription by RNA polymerase II; IDA:ParkinsonsUK-UCL. DR GO; GO:0006357; P:regulation of transcription by RNA polymerase II; IBA:GO_Central. DR GO; GO:0034976; P:response to endoplasmic reticulum stress; IDA:ParkinsonsUK-UCL. DR GO; GO:0007165; P:signal transduction; TAS:ProtInc. DR CDD; cd14700; bZIP_ATF6; 1. DR Gene3D; 1.20.5.170; -; 1. DR InterPro; IPR004827; bZIP. DR InterPro; IPR046347; bZIP_sf. DR PANTHER; PTHR46164; ATF6, ISOFORM C; 1. DR PANTHER; PTHR46164:SF2; CYCLIC AMP-DEPENDENT TRANSCRIPTION FACTOR ATF-6 BETA; 1. DR Pfam; PF00170; bZIP_1; 1. DR SMART; SM00338; BRLZ; 1. DR SUPFAM; SSF57959; Leucine zipper domain; 1. DR PROSITE; PS50217; BZIP; 1. DR PROSITE; PS00036; BZIP_BASIC; 1. DR Genevisible; Q99941; HS. PE 1: Evidence at protein level; KW Acetylation; Activator; Alternative splicing; DNA-binding; KW Endoplasmic reticulum; Glycoprotein; Membrane; Nucleus; Reference proteome; KW Signal-anchor; Transcription; Transcription regulation; Transmembrane; KW Transmembrane helix; Unfolded protein response. FT INIT_MET 1 FT /note="Removed" FT /evidence="ECO:0007744|PubMed:22223895, FT ECO:0007744|PubMed:22814378" FT CHAIN 2..703 FT /note="Cyclic AMP-dependent transcription factor ATF-6 FT beta" FT /id="PRO_0000076590" FT CHAIN 2..? FT /note="Processed cyclic AMP-dependent transcription factor FT ATF-6 beta" FT /id="PRO_0000296201" FT TOPO_DOM 2..396 FT /note="Cytoplasmic" FT /evidence="ECO:0000255" FT TRANSMEM 397..417 FT /note="Helical; Signal-anchor for type II membrane protein" FT /evidence="ECO:0000255" FT TOPO_DOM 418..703 FT /note="Lumenal" FT /evidence="ECO:0000255" FT DOMAIN 325..388 FT /note="bZIP" FT /evidence="ECO:0000255|PROSITE-ProRule:PRU00978" FT REGION 2..86 FT /note="Transcription activation" FT REGION 87..114 FT /note="Disordered" FT /evidence="ECO:0000256|SAM:MobiDB-lite" FT REGION 229..248 FT /note="Disordered" FT /evidence="ECO:0000256|SAM:MobiDB-lite" FT REGION 293..317 FT /note="Disordered" FT /evidence="ECO:0000256|SAM:MobiDB-lite" FT REGION 327..347 FT /note="Basic motif" FT /evidence="ECO:0000255|PROSITE-ProRule:PRU00978" FT REGION 350..357 FT /note="Leucine-zipper" FT /evidence="ECO:0000255|PROSITE-ProRule:PRU00978" FT REGION 447..479 FT /note="Disordered" FT /evidence="ECO:0000256|SAM:MobiDB-lite" FT REGION 521..565 FT /note="Disordered" FT /evidence="ECO:0000256|SAM:MobiDB-lite" FT REGION 660..703 FT /note="Disordered" FT /evidence="ECO:0000256|SAM:MobiDB-lite" FT COMPBIAS 89..112 FT /note="Polar residues" FT /evidence="ECO:0000256|SAM:MobiDB-lite" FT COMPBIAS 295..316 FT /note="Pro residues" FT /evidence="ECO:0000256|SAM:MobiDB-lite" FT COMPBIAS 450..478 FT /note="Polar residues" FT /evidence="ECO:0000256|SAM:MobiDB-lite" FT COMPBIAS 660..675 FT /note="Polar residues" FT /evidence="ECO:0000256|SAM:MobiDB-lite" FT COMPBIAS 682..703 FT /note="Polar residues" FT /evidence="ECO:0000256|SAM:MobiDB-lite" FT SITE 410 FT /note="Important for cleavage by MBTPS2" FT /evidence="ECO:0000250|UniProtKB:P18850" FT SITE 413 FT /note="Important for cleavage by MBTPS2" FT /evidence="ECO:0000250|UniProtKB:P18850" FT SITE 440..441 FT /note="Cleavage; by MBTPS1" FT /evidence="ECO:0000250|UniProtKB:P18850" FT MOD_RES 2 FT /note="N-acetylalanine" FT /evidence="ECO:0007744|PubMed:22223895, FT ECO:0007744|PubMed:22814378" FT CARBOHYD 476 FT /note="N-linked (GlcNAc...) asparagine" FT /evidence="ECO:0000255" FT CARBOHYD 505 FT /note="N-linked (GlcNAc...) asparagine" FT /evidence="ECO:0000255" FT CARBOHYD 610 FT /note="N-linked (GlcNAc...) asparagine" FT /evidence="ECO:0000255" FT CARBOHYD 627 FT /note="N-linked (GlcNAc...) asparagine" FT /evidence="ECO:0000255" FT CARBOHYD 676 FT /note="N-linked (GlcNAc...) asparagine" FT /evidence="ECO:0000255" FT VAR_SEQ 28..31 FT /note="GLQN -> D (in isoform 1)" FT /evidence="ECO:0000303|PubMed:8586413" FT /id="VSP_000593" FT CONFLICT 3 FT /note="E -> D (in Ref. 2; CAA66664)" FT /evidence="ECO:0000305" FT CONFLICT 329..330 FT /note="QQ -> HE (in Ref. 2; CAA66664)" FT /evidence="ECO:0000305" FT CONFLICT 520 FT /note="V -> D (in Ref. 6; AAC50888)" FT /evidence="ECO:0000305" FT CONFLICT 600 FT /note="D -> G (in Ref. 1; AAA97438)" FT /evidence="ECO:0000305" SQ SEQUENCE 703 AA; 76709 MW; B04C7B23E7D83F82 CRC64; MAELMLLSEI ADPTRFFTDN LLSPEDWGLQ NSTLYSGLDE VAEEQTQLFR CPEQDVPFDG SSLDVGMDVS PSEPPWELLP IFPDLQVKSE PSSPCSSSSL SSESSRLSTE PSSEALGVGE VLHVKTESLA PPLCLLGDDP TSSFETVQIN VIPTSDDSSD VQTKIEPVSP CSSVNSEASL LSADSSSQAF IGEEVLEVKT ESLSPSGCLL WDVPAPSLGA VQISMGPSLD GSSGKALPTR KPPLQPKPVV LTTVPMPSRA VPPSTTVLLQ SLVQPPPVSP VVLIQGAIRV QPEGPAPSLP RPERKSIVPA PMPGNSCPPE VDAKLLKRQQ RMIKNRESAC QSRRKKKEYL QGLEARLQAV LADNQQLRRE NAALRRRLEA LLAENSELKL GSGNRKVVCI MVFLLFIAFN FGPVSISEPP SAPISPRMNK GEPQPRRHLL GFSEQEPVQG VEPLQGSSQG PKEPQPSPTD QPSFSNLTAF PGGAKELLLR DLDQLFLSSD CRHFNRTESL RLADELSGWV QRHQRGRRKI PQRAQERQKS QPRKKSPPVK AVPIQPPGPP ERDSVGQLQL YRHPDRSQPA FLDAIDRRED TFYVVSFRRD HLLLPAISHN KTSRPKMSLV MPAMAPNETL SGRGAPGDYE EMMQIECEVM DTRVIHIKTS TVPPSLRKQP SPTPGNATGG PLPVSAASQA HQASHQPLYL NHP //